STAAR Surgical (NASDAQ:STAA) Given New $125.00 Price Target at Jefferies Financial Group
STAAR Surgical (NASDAQ:STAA) Given New $125.00 Price Target at Jefferies Financial Group
STAAR Surgical (NASDAQ:STAA – Get Rating) had its target price cut by Jefferies Financial Group from $165.00 to $125.00 in a research report released on Thursday morning, The Fly reports.
據The Fly報道，傑富瑞金融集團週四上午發佈的一份研究報告將星空外科(納斯達克：STAA-GET評級)的目標價從165.00美元下調至125.00美元。
A number of other equities analysts also recently weighed in on the company. BTIG Research upped their target price on STAAR Surgical from $98.00 to $103.00 in a report on Thursday. Canaccord Genuity Group upped their target price on STAAR Surgical from $81.00 to $89.00 and gave the company a buy rating in a report on Tuesday, April 26th. Canaccord Genuity Group upped their target price on STAAR Surgical from $81.00 to $89.00 and gave the company a buy rating in a report on Tuesday, April 26th. Benchmark increased their price objective on STAAR Surgical from $97.00 to $117.00 and gave the stock a buy rating in a report on Thursday. Finally, Needham & Company LLC increased their price objective on STAAR Surgical from $87.00 to $110.00 and gave the stock a buy rating in a report on Thursday. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to data from MarketBeat, STAAR Surgical presently has an average rating of Moderate Buy and an average target price of $106.83.
其他一些股票分析師最近也對該公司進行了分析。BTIG Research在週四的一份報告中將STAAR Surgical的目標價從98.00美元上調至103.00美元。Cancord Genuity Group在4月26日週二的一份報告中將STAAR Surgical的目標價從81.00美元上調至89.00美元，並給出了該公司的買入評級。Cancord Genuity Group在4月26日週二的一份報告中將STAAR Surgical的目標價從81.00美元上調至89.00美元，並給出了該公司的買入評級。Benchmark將STAAR Surgical的目標價從97美元上調至117.00美元，並在週四的一份報告中給予該股買入評級。最後，Needham&Company LLC將STAAR Surgical的目標價從87美元上調至110.00美元，並在週四的一份報告中給予該股買入評級。一位股票研究分析師對該股的評級為持有，五位分析師對該公司的評級為買入。根據MarketBeat的數據，STAAR Surgical目前的平均評級為中等買入，平均目標價為106.83美元。
STAAR Surgical Trading Up 9.4 %
STAAR外科手術類股上漲9.4%
NASDAQ STAA opened at $111.58 on Thursday. The stock's 50-day moving average price is $75.73 and its two-hundred day moving average price is $70.75. The company has a market cap of $5.33 billion, a PE ratio of 166.54 and a beta of 1.09. STAAR Surgical has a 1 year low of $49.03 and a 1 year high of $163.08.
新浪納斯達克週四開盤報111.58美元。該股的50日移動均線價格為75.73美元，200日移動均線價格為70.75美元。該公司市值為53.3億美元，市盈率為166.54，貝塔係數為1.09.STAAR Surgical的一年低點為49.03美元，一年高位為163.08美元。
Insiders Place Their Bets
內部人士下注
In other STAAR Surgical news, CEO Caren L. Mason sold 35,000 shares of the company's stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $57.49, for a total transaction of $2,012,150.00. Following the completion of the sale, the chief executive officer now owns 83,645 shares of the company's stock, valued at $4,808,751.05. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 2.60% of the company's stock.
在另一則STAAR Surgical新聞中，首席執行官卡倫·L·梅森在5月19日星期四的一筆交易中出售了3.5萬股該公司股票。股票以57.49美元的平均價格出售，總成交金額為2,012,150.00美元。出售完成後，首席執行官現在擁有83,645股公司股票，價值4,808,751.05美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，人們可以通過美國證券交易委員會網站查看這份文件。公司內部人士持有該公司2.60%的股份。
Institutional Investors Weigh In On STAAR Surgical
機構投資者參與STAAR Surgical
Large investors have recently added to or reduced their stakes in the stock. Allegheny Financial Group LTD bought a new stake in STAAR Surgical during the fourth quarter worth approximately $25,000. Rise Advisors LLC bought a new stake in STAAR Surgical during the fourth quarter worth approximately $25,000. Covestor Ltd bought a new stake in shares of STAAR Surgical in the fourth quarter valued at approximately $39,000. Lazard Asset Management LLC boosted its position in shares of STAAR Surgical by 131.1% in the first quarter. Lazard Asset Management LLC now owns 684 shares of the medical instruments supplier's stock valued at $54,000 after acquiring an additional 388 shares during the period. Finally, UBS Group AG boosted its position in shares of STAAR Surgical by 130.7% in the second quarter. UBS Group AG now owns 805 shares of the medical instruments supplier's stock valued at $57,000 after acquiring an additional 456 shares during the period. Institutional investors own 89.93% of the company's stock.
大型投資者最近增持或減持了該股。阿勒格尼金融集團有限公司在第四季度購買了STAAR Surgical的新股份，價值約2.5萬美元。Rise Advisors LLC在第四季度購買了STAAR Surgical的新股份，價值約2.5萬美元。Covestor Ltd在第四季度購買了STAAR Surgical的新股份，價值約3.9萬美元。Lazard Asset Management LLC在第一季度將其在STAAR Surgical的股票頭寸增加了131.1%。Lazard Asset Management LLC在此期間額外收購了388股，現在擁有這家醫療器械供應商684股股票，價值54,000美元。最後，瑞銀集團(UBS Group AG)在第二季度將其在STAAR Surgical的股票頭寸提高了130.7%。瑞銀集團(UBS Group AG)在此期間增持了456股，目前持有這家醫療器械供應商805股股票，價值5.7萬美元。機構投資者持有該公司89.93%的股票。
STAAR Surgical Company Profile
STAAR外科公司簡介
(Get Rating)
(獲取評級)
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.
STAAR Surgical Company與其子公司一起設計、開發、製造、營銷和銷售眼科植入性鏡片，以及將鏡片輸送到眼睛內的配套輸送系統。該公司提供治療近視、遠視、散光和老花眼等視覺障礙的Visian植入式Collamer透鏡產品系列(ICL)，以及治療遠視的遠視ICL。
Recommended Stories
推薦故事
- Get a free copy of the StockNews.com research report on STAAR Surgical (STAA)
- Here is a Simple 4 Stock Portfolio that Can Outperform the Market
- Is AMC Entertainment Pulling a Fast One on the APEs?
- Here's How the Inflation Reduction Act Energizes Power Stock
- 2 Important Retail Stock Battles to Watch
- MarketBeat: Week in Review 8/8 – 8/12
- 免費獲取StockNews.com關於STAAR Surgical(STAA)的研究報告
- 以下是一個簡單的4只股票投資組合，它可以跑贏大盤
- AMC娛樂公司是在對猩猩採取快速行動嗎？
- 以下是《降低通脹法案》如何提振電力庫存
- 值得關注的兩場重要的零售股大戰
- MarketBeat：回顧中的一週2012-8-8
Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
接受《STAAR外科日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對STAAR外科及相關公司的最新新聞和分析師評級的每日簡要摘要。
譯文內容由第三人軟體翻譯。